Evidence map›Paper›PMID 32446652›Full record

ArticleResearch in social & administrative pharmacy : RSAP2021

Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.

Hisham A Badreldin, Bassam Atallah

Open access · greenAbstract read
In one paragraph

Article in Research in social & administrative pharmacy : RSAP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
41.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Journal of traditional and complementary medicine · 2024
    Article
  9. Managing medicine shortages.Australian prescriber · 2024
    Review
  10. How do South African policies address provision of contraception among adolescents?African journal of primary health care & family medicine · 2024
    Review
  11. Trend of pharmaceuticals 3D printing in the Middle East and North Africa (MENA) region: An overview, regulatory perspective and future outlook.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  12. Article
  13. Review
  14. The Impact of COVID-19 on Children and Adolescents with Chronic Illness.Advances in experimental medicine and biology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Exploring Drug Shortages in the United Kingdom.Pharmacy (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Medicine shortages in France: a 6-year retrospective study in a university medical centre.European journal of hospital pharmacy : science and practice · 2023
    Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Hisham A BadreldinDepartment of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia. Electronic address: Aldeenh@ksau-hs.edu.sa.
Bassam AtallahDepartment of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Cleveland Clinic Lerner College of Medicine · USKing Saud bin Abdulaziz University for Health Sciences · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem.

Indexed as

COVID-19HumansPatient CarePharmaceutical PreparationsPharmaceutical ServicesPharmacistsPolicy MakingProfessional RolePharmaceutical PreparationsCoronavirusCOVID-19Drug shortagePandemicPharmacistPolicymaker

Identifiers

PMID32446652
PMCPMC7235598
OpenAlexW3025780634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.